线粒体
钙
生物能学
细胞生物学
粒线体疾病
Wolfram综合征
未折叠蛋白反应
生物
平衡
化学
内分泌学
内科学
线粒体DNA
基因
生物化学
医学
内质网
作者
Mailis Liiv,Annika Vaarmann,Dzhamilja Safiulina,Vinay Choubey,Ruby Gupta,Malle Kuum,Lucia Janickova,Zuzana Hodurova,Michal Cagalinec,Akbar Zeb,Miriam A. Hickey,Yi‐Long Huang,Nana Gogichaishvili,Merle Mandel,Mario Plaas,Eero Vasar,Jens Loncke,Tim Vervliet,Ting‐Fen Tsai,Geert Bultynck
标识
DOI:10.1038/s41467-024-50502-x
摘要
Abstract Wolfram syndrome is a rare genetic disease caused by mutations in the WFS1 or CISD2 gene. A primary defect in Wolfram syndrome involves poor ER Ca 2+ handling, but how this disturbance leads to the disease is not known. The current study, performed in primary neurons, the most affected and disease-relevant cells, involving both Wolfram syndrome genes, explains how the disturbed ER Ca 2+ handling compromises mitochondrial function and affects neuronal health. Loss of ER Ca 2+ content and impaired ER-mitochondrial contact sites in the WFS1- or CISD2-deficient neurons is associated with lower IP 3 R-mediated Ca 2+ transfer from ER to mitochondria and decreased mitochondrial Ca 2+ uptake. In turn, reduced mitochondrial Ca 2+ content inhibits mitochondrial ATP production leading to an increased NADH/NAD + ratio. The resulting bioenergetic deficit and reductive stress compromise the health of the neurons. Our work also identifies pharmacological targets and compounds that restore Ca 2+ homeostasis, enhance mitochondrial function and improve neuronal health.
科研通智能强力驱动
Strongly Powered by AbleSci AI